Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of Rheumatology 2000-Jun

Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality.

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
M M Ward

キーワード

概要

OBJECTIVE

Valid comparison of patient outcomes among hospitals requires adjustment for differences in the severity of patients' illness. Disease-specific indexes of severity of illness may permit more accurate risk adjustment than generic indexes. The objective of this study was to develop a systemic lupus-specific risk adjustment index for in-hospital mortality, and to compare its performance to that of the generic Charlson index.

METHODS

A systemic lupus-specific risk adjustment index was developed using discharge abstract data from a 50% random sample (n = 4994) of patients with systemic lupus erythematosus (SLE) hospitalized on an emergent or urgent basis in California from 1991 to 1994 (n = 9989). The index was tested on the remaining members of the sample. Candidate variables for the index were the diagnoses included in the original Charlson index, and nephritis, chronic renal failure, pericarditis, pleuritis, psychosis, seizures, hemolytic anemia, and thrombocytopenia. Multivariate logistic regression analysis was used to identify the set of variables that best differentiated those patients who died in the hospital from those who survived, and to provide the weights for construction of the index.

RESULTS

In the derivation set of patients, the SLE-specific index accurately predicted in-hospital mortality (area under the receiver operating characteristic curve c = 0.79). In the test set, the SLE-specific index (c = 0.72) was similar to the original Charlson index (c = 0.74) in its ability to predict in-hospital mortality (p = 0.32). However, the SLE-specific index accounted for substantially more variation in the risk of mortality among patients (R2 = 0.069) than did the Charlson index (R2 = 0.036). Use of the SLE-specific index rather than the Charlson index for risk adjustment did not alter the association between hospital experience and the probability of in-hospital mortality. Results were similar in the subgroups of patients with emergent hospitalizations and those with emergent hospitalizations due to SLE.

CONCLUSIONS

The SLE-specific risk adjustment index developed from diagnoses recorded in administrative discharge abstracts performed similarly to the generic Charlson index in correctly classifying mortality outcomes, but the SLE-specific index stratified patients by their level of risk of mortality better than the Charlson index. Adjustment for SLE-specific risks of mortality did not alter the association between hospital experience and the risk of in-hospital mortality.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge